Home Overview Press Room Blog Publications For Students about us

Patents & Other IP : Displaying 208-217 of 327

U.S. invalidates three human stem cell patentsby Karen KaplanLos Angeles TimesApril 4th, 2007The U.S. Patent and Trademark Office has invalidated three broad patents for human embryonic stem cells that have been blamed for slowing research in the highly visible field of regenerative medicine.
CGS letter on California's SB771April 4th, 2007CGS supports, if amended, SB771. We are concerned that the bill as currently written does not go far enough to protect Californians from potentially unfair pricing practices.
Restrictive Stem Cell Patents Overturnedby Jesse ReynoldsBiopolitical TimesApril 4th, 2007The licensing arm of the University of Wisconsin has long been criticized for its patents in embryonic stem cell research. Earlier this week, a federal agency agreed with these sentiments, and invalidated its stem cell patents.
Genetic justice, industry styleby Marcy DarnovskyBiopolitical TimesMarch 19th, 2007The issues raised by the intertwining of law and human biotechnologies are often technically and socially complex. What's a busy jurist to do?
Neurolawby Osagie K. ObasogieBiopolitical TimesMarch 13th, 2007Should courts be in the business of deciding when to mitigate someone's criminal responsibility because his brain functions improperly, whether because of age, in-born defects or trauma?
Bill to End Human Gene Patents Introduced in HouseGenetic CrossroadsFebruary 28th, 2007Hoping to end patents on human genes and genetic material, Representatives Xavier Becerra (D-CA) and Dave Weldon (R-FL) have introduced HR 977, the Genomic Research and Accessibility Act.
Congressmen Introduce Bill to End Gene Patentsby Osagie K. ObasogieBiopolitical TimesFebruary 28th, 2007Patenting genes has become a burgeoning biotech business model.
Public Interest Group Welcomes Bill to Ensure Stem Cell Institute’s PromisesFebruary 23rd, 2007Center for Genetics and Society says California agency must provide for affordable treatments and returns to the state
Patenting Lifeby Michael CrichtonNew York TimesFebruary 13th, 2007YOU, or someone you love, may die because of a gene patent that should never have been granted in the first place. Sound far-fetched? Unfortunately, it’s only too real.
The Biotech Bubble: Why stem-cell research won't make states rich.by David HamiltonSlateFebruary 6th, 2007As Congress hunts for ways to push its stem-cell bill past an expected veto, states are charging ahead on their own, but the economic rationale seems hopelessly optimistic.
Displaying 208-217 of 327  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760